AstraZeneca PLC (ZEGA) — Cash Flow Reinvestment Rate
AstraZeneca PLC (ZEGA) has a Cash Flow Reinvestment Rate of 0.73x as of September 2025, reinvesting €3.73 Billion (capex €1.73 Billion plus investments €-2.00 Billion) from operating cash flow of €5.13 Billion. See cash generation quality of AstraZeneca PLC to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
AstraZeneca PLC Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for AstraZeneca PLC across 11 annual periods. For the full cash flow conversion analysis, see AstraZeneca PLC (ZEGA) cash flow conversion.
Annual Cash Flow Reinvestment Rate for AstraZeneca PLC (2014–2024)
Year-by-year capital reinvestment analysis for AstraZeneca PLC. See AstraZeneca PLC financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.06x | €12.57 Billion | €11.86 Billion | €4.59 Billion | ▲ +65.8% |
| 2023 | 0.64x | €6.62 Billion | €10.36 Billion | €3.39 Billion | ▲ +407.9% |
| 2022 | 0.13x | €1.23 Billion | €9.81 Billion | €1.09 Billion | ▼ -55.8% |
| 2021 | 0.28x | €1.70 Billion | €5.96 Billion | €1.09 Billion | ▼ -53.9% |
| 2020 | 0.62x | €2.96 Billion | €4.80 Billion | €961.00 Million | ▲ +65.9% |
| 2019 | 0.37x | €1.10 Billion | €2.97 Billion | €979.00 Million | ▼ -17.7% |
| 2018 | 0.45x | €1.18 Billion | €2.62 Billion | €1.04 Billion | ▼ -8.8% |
| 2017 | 0.50x | €1.77 Billion | €3.58 Billion | €1.33 Billion | ▼ -67.3% |
| 2016 | 1.52x | €6.28 Billion | €4.14 Billion | €2.31 Billion | ▲ +214.5% |
| 2015 | 0.48x | €1.60 Billion | €3.32 Billion | €1.33 Billion | ▲ +204.0% |
| 2014 | 0.16x | €1.12 Billion | €7.06 Billion | €1.01 Billion | — |